drugset / Trial / NCT06680544
Role of Oral Voriconazole in the Treatment of Resistant Dermatophyte Infections
RandomizedParallel-groupOpen-labelTreatment
Summary
Treatment of dermatophyte infection in our country (Pakistan) is becoming difficult due to the developing resistance to traditional antifungal agents. Assessing the effectiveness ,feasibility and standard dosage of a newer antifungal drug like voriconazole is the need of the hour in resistant cases of dermatophyte infection.
Timeline
- Start
- 2024-11-15
- Primary completion
- 2025-03-01
- Completion
- 2025-03-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Voriconazole | Small molecule | 200 mg | Oral |